Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma

Teymouri, M. and Farzaneh, H. and Badiee, A. and Golmohammadzadeh, S. and Sadri, K. and Jaafari, M. R. (2015) Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma. European Journal of Pharmaceutical Sciences, 80. pp. 66-73.

[img] Other (Article)
S0928098715003668

Download (69kB)
Item Type: Article
Additional Information: Cited By :13 Export Date: 7 July 2020
Subjects: QV pharmacology
Divisions: Mashhad University of Medical Sciences
Depositing User: mr lib5 lib5
Date Deposited: 22 Jul 2020 09:21
Last Modified: 22 Jul 2020 09:21
URI: http://eprints.mums.ac.ir/id/eprint/22627

Actions (login required)

View Item View Item